hPSCreg®
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our Privacy Policy for details. This website uses cookies, learn more

Search results

Sort by:

Filter by:

  1. WAe009-A-36 (JPH2-KO)

    China Anzhen Hospital (ANZHEN)
    Disease:

    Hypertrophic cardiomyopathy

  2. ASGRCi002-A (F3-3#1 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 1 diabetes mellitus

  3. ASGRCi003-A (F3-4#5 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 1 diabetes mellitus

  4. ATLABi008-A (AT-UC I Normal-iC06)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  5. ATLABi009-A (AT-UC I Normal-iC13)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  6. BCMi001-B (M22c8 and HSCC-003iPS-Sc8)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal

  7. BCRTi002-A (P02-1)

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Fibrodysplasia ossificans progressiva

  8. BCRTi007-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Polycystic kidney disease

  9. BIHi001-A-1 (iBCRT Cas9v1-3G-Kl.16)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  10. SIGi001-A-14 (SIGi001-A Bi-Allelic MAPT HA-tag)

    Denmark Bioneer (BION)
    Disease:

    Normal

  11. SIGi001-A-16 (SIGi001-A-9 Bi-Allelic MAPT HA-tag)

    Denmark Bioneer (BION)
    Disease:

    Frontotemporal dementia

  12. STBCi006-A-1 (ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  13. BUCREMi001-A (iPSC-S6D63H-1-hom)

    United States Boston University (BUCREM)
    Disease:

    Lethal brain and heart developmental defects

  14. CAMi014-A (A1ATD1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Alpha-1-antitrypsin deficiency

  15. CBDTi001-A

    India Institute for Stem Cell Science and Regenerative Medicine (CBDT)
    Disease:

    Normal

  16. CBIGi001-A (AIW002-02)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Normal

  17. CCMi001-A (DMD1)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Duchenne muscular dystrophy

  18. CHCMUi002-A

    China Children's hospital of Chongqing Medical University (CHCMU)
    Disease:

    Chronic granulomatous disease

  19. CHUVi001-A

    Switzerland Centre Hospitalier Universitaire Vaudois (CHUV)
    Disease:

    Normal

  20. CIRMi285-A (CW70022)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  21. CIRMi286-A (CW70028)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  22. CIRMi287-A (CW70029)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  23. CIRMi292-A (CW70035)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  24. CIRMi293-A (CW70036)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  25. CIRMi294-A (CW70037)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  26. CIRMi307-A (CW70052)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  27. CIRMi314-A (CW70064)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  28. CIRMi323-A (CW70085)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  29. CIRMi329-A (CW70091)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  30. CIRMi361-A (CW70129)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  31. CIRMi373-A (CW70143)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  32. CIRMi419-A (CW70208)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  33. CIRMi451-A (CW70254)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  34. CIRMi484-A (CW70296)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  35. CIRMi498-A (CW70313)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  36. CIRMi499-A (CW70314)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  37. CIRMi505-A (CW70320)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  38. CIRMi511-A (CW70326)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Diabetic retinopathy

  39. CIRMi526-A (CW70350)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  40. CIRMi528-A (CW70353)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  41. CIRMi538-A (CW70369)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Type 1 diabetes mellitus

  42. CMGANTi003-A (SEMD1)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    X-linked spondyloepimetaphyseal dysplasia

  43. CMGANTi004-A (SEMD2)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    X-linked spondyloepimetaphyseal dysplasia

  44. CMGANTi006-A (SEDC1)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Spondyloepiphyseal dysplasia congenita

  45. CMGANTi007-A (SEDC2)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Spondyloepiphyseal dysplasia congenita

  46. CMGANTi008-A (iPSC_MFS_FBN1_Fi930129_C8)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Marfan syndrome

  47. CRICKi004-A (iFCI008)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy with lower extremity predominant

  48. CRICKi005-A (iFCI004)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy

  49. CRICKi006-A (iFCI005)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy

  50. CRICKi007-A (iFCI009)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy with lower extremity predominant

  51. CRICKi008-A (iFCI006 and NH13-0078)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    X-linked centronuclear myopathy

  52. CRICKi009-A (iFCI012)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Vhl

  53. CRICKi010-A (iFCI013)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Vhl

  54. CRICKi011-A (iFCI016)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Young-onset parkinson disease

  55. CRICKi012-A (iFCI017)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Young-onset parkinson disease

  56. CRICKi013-A (iFCI018 Clone 6)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Von hippel-lindau disease tumor suppressor

  57. CRICKi014-A (iFCI019 Clone 4)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Von hippel-lindau disease tumor suppressor

  58. CRICKi015-A (iFCI020 Clone 1)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Von hippel-lindau disease tumor suppressor

  59. CRTDi001-A (T12.9 and C1-1)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  60. CSSi001-A (Joub03cl2 and COR419)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Joubert syndrome

  61. CSSi015-A (FC17)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Normal

  62. CSUXHi003-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Waardenburg syndrome type 2

  63. CSUXHi004-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Waardenburg syndrome type 1

  64. CTEFi001-A (CTEF-hiPSC10 and FNUSA-hiPSC10)

    Czech Republic Cell and Tissue Engineering Facility (CTEF)
    Disease:

    Normal

  65. DMBi001-A-2

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Normal

  66. WAe009-A-58 (COL4A5 heterozygote)

    China Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (DZMH)
    Disease:

    Alport syndrome

  67. EDi010-A (RCi136)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  68. EDi010-B (RCi138)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  69. EDi011-B (RCi140)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  70. EDi011-C (RCi141)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  71. EDi018-B (RCi212)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  72. EDi018-C (RCi213)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  73. EDi046-A

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  74. EHTJUi002-A (DF-GMP-ZB11AR-H)

    China East Hospital Affiliated to Tongji University (EHTJU)
    Disease:

    Normal

  75. EHTJUi004-A (DF-GMP-ZB12AN-I)

    China East Hospital Affiliated to Tongji University (EHTJU)
    Disease:

    Normal

  76. ESi065-A ([IDDM1] FiPS 1.13-Ep6F-9)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsolete_type i diabetes mellitus

  77. ESi080-A (N1-FiPS4F#7)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal

  78. FDCHDPi001-A (FDCHDP01)

    China Fudan University (FDCHDP)
    Disease:

    Tourette syndrome

  79. GENEAe008-A (GENEA009 and SIVF09)

    Australia Genea (GENEA)

  80. GENEAe013-A (GENEA089)

    Australia Genea (GENEA)
    Disease:

    Huntington disease

  81. GENEAe014-A (GENEA029)

    United States Genea (GENEA)
    Disease:

    Normal

  82. GENEAe015-A (GENEA020)

    United States Genea (GENEA)
    Disease:

    Huntington disease

  83. GENEAe017-A (GENEA023)

    Australia Genea (GENEA)
    Disease:

    Normal

  84. GENEAe018-A (GENEA090)

    Australia Genea (GENEA)
    Disease:

    Huntington disease

  85. GENEAe019-A (GENEA091)

    Australia Genea (GENEA)
    Disease:

    Huntington disease

  86. GENYOi001-A (PBMC1-iPS4F1)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Normal

  87. GENYOi003-A (PBMC2-iPS4F8)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Normal

  88. GENYOi004-A (ASD-PBMC-iPS4F2)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Adnp syndrome

  89. GENYOi005-A (FPD/AML-PBMC-iPSC4F73)

    Spain Centre for Genomics and Oncological Research (GENYO)
    Disease:

    Familial platelet disorder with associated myeloid malignancy

  90. WAe009-A-84

    China Guangxi Institute of Cardiovascular Diseases (GICD)
    Disease:

    Congenital heart disease

  91. HEBHMUi010-A

    China Hebei Medical University (HEBHMU)
    Disease:

    Normal

  92. HELPi001-A (BS-TL-1)

    China Help Stem Cell Innovations Co.Ltd. (HELP)
    Disease:

    Congenital contractural arachnodactyly

  93. HHUi003-B (A4_C1)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Maternally-inherited leigh syndrome

  94. HHUi003-C (A4_W1)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Maternally-inherited leigh syndrome

  95. HHUi006-A (11656_H)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Normal

  96. HHUi006-B (11656_K)

    Germany Universitätsklinikum Düsseldorf (HHU)
    Disease:

    Normal

  97. HNMUi009-A (iPS-UC1171)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  98. HVRDi005-A (BJ SiPS-D)

    United States Harvard University (HVRD)
    Disease:

    Normal

  99. IBPi002-A (P71 iPSCs 1)

    Czech Republic Institute of Biophysics of the Czech Academy of Sciences (IBP)
    Disease:

    Prostate adenocarcinoma

  100. ICANi001-A (CDGEN1.16)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Hypertrophic cardiomyopathy

  101. ICANi001-A-1 (CDGEN1.16.40.5)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Hypertrophic cardiomyopathy

  102. ICANi002-A (ICAN-403.3)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Normal

  103. ICANi002-A-1 (ICAN-FLNC42.1)

    France INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
    Disease:

    Normal

  104. ICGi002-A (DMD1_1)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Duchenne muscular dystrophy

  105. ICGi002-B (DMD1_4)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Duchenne muscular dystrophy

  106. ICGi002-C (DMD1_11)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Duchenne muscular dystrophy

  107. ICGi003-A (f3SMA3)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Spinal muscular atrophy type 3

  108. ICGi005-A (iSMA40)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 1

  109. ICGi005-B (iSMA37)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 1

  110. ICGi006-A (m3SMA13)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 2

  111. ICGi006-B (m3SMA20)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Proximal spinal muscular atrophy type 2

  112. ICGi007-A (47Q-3Lf)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington disease

  113. ICGi009-A (iTAF3-17 and iTAF3del17)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  114. ICGi009-B (iTAF3del37 and iTAF3-37)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  115. ICGi013-A (iTAF13-26 and iTAF13del26)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  116. ICGi013-B (iTAF13del27 and iTAF13-27)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Intellectual disability

  117. ICGi015-B-1 (m6.7pCyto-17)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Parkinson's disease

  118. ICGi018-A (iHD38Q-3)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington's disease

  119. ICGi018-B (iHD38Q-2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington's disease

  120. ICGi018-C (iHD38Q-1)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Huntington's disease

  121. ICGi019-A (HCM1f6)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Hypertrophic cardiomyopathy

  122. ICGi019-B (HCM1f33)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Hypertrophic cardiomyopathy

  123. ICGi021-A (K6-4f)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Normal

  124. ICGi021-A-1 (K6-4fpCyto-13)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Healthy

  125. ICGi022-A (K7-4Lf)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Normal

  126. ICGi025-A (iTAF11-4)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Developmental delay

  127. ICGi028-A (HCM4fm5.2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Hypertrophic cardiomyopathy

  128. ICGi029-A (HCM14fm6.2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Hypertrophic cardiomyopathy

  129. ICGi030-A (HF2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Wilson disease

  130. IGIBi002-A

    India CSIR-Institute of Genomics and Integrative Biology (IGIB)
    Disease:

    Beta-thalassemia

  131. IMBPASi001-A (iPSC-WFS1-#1)

    Poland Institute of Medical Biology of Polish Academy of Sciences (IMBPAS)
    Disease:

    Wolfram syndrome 1

  132. IMGTi001-A (iTAF5-29)

    Russia Research Institute of Medical Genetics, TNMRC (IMGT)
    Disease:

    Monosomy 22q13.3

  133. INSRMi002-A (PC117_c2)

    France INSERM (INSRM)
    Disease:

    Epilepsy

  134. INSRMi003-A (PC128_c5)

    France INSERM (INSRM)
    Disease:

    Normal

  135. INSRMi004-A (PC118_c7)

    France INSERM (INSRM)
    Disease:

    Epilepsy

  136. INSRMi005-A (PC119_c7)

    France INSERM (INSRM)
    Disease:

    Normal

  137. INSRMi006-A (PC131_c8)

    France INSERM (INSRM)
    Disease:

    Epilepsy

  138. INSRMi007-A (pc132-c4)

    France INSERM (INSRM)
    Disease:

    Normal

  139. INSRMe002-A (STR-I-233-FRAXA)

    France INSERM (INSRM)
    Disease:

    Fragile x syndrome

  140. INSRMe003-A (STR-I-155-HD)

    France INSERM (INSRM)
    Disease:

    Huntington disease

  141. INSRMe004-A (STR-I-171-GLA)

    France INSERM (INSRM)
    Disease:

    Fabry disease

  142. INSRMe005-A (STR-I-189-FRAXA)

    France INSERM (INSRM)
    Disease:

    Fragile x syndrome

  143. INSRMe006-A (STR-I-209-MEN2a)

    France INSERM (INSRM)
    Disease:

    Endocrine gland cancer

  144. INSRMe007-A (STR-I-211-MEN2a)

    France INSERM (INSRM)
    Disease:

    Endocrine gland cancer

  145. INSRMe008-A (STR-I-203-CFTR)

    France INSERM (INSRM)
    Disease:

    Cystic fibrosis

  146. INSRMe009-A (STR-I-251-CFTR)

    France INSERM (INSRM)
    Disease:

    Cystic fibrosis

  147. INSRMe010-A (STR-I-221-Sca2)

    France INSERM (INSRM)
    Disease:

    Autosomal dominant cerebellar ataxia

  148. INSRMe011-A (STR-I-229-MTMX)

    France INSERM (INSRM)
    Disease:

    X-linked myopathy with excessive autophagy

  149. INSRMe012-A (STR-I-231-MTMX)

    France INSERM (INSRM)
    Disease:

    X-linked myopathy with excessive autophagy

  150. INSRMe013-A (STR-I-301-MFS)

    France INSERM (INSRM)
    Disease:

    Marfan syndrome

  151. INSRMe014-A (STR-I-305-APC)

    France INSERM (INSRM)
    Disease:

    Familial adenomatous polyposis

  152. INSRMe015-A (STR-I-315-CMT1a)

    France INSERM (INSRM)
    Disease:

    Charcot-marie-tooth disease type 1

  153. INSRMe016-A (STR-I-347-FRAXA)

    France INSERM (INSRM)
    Disease:

    Fragile x syndrome

  154. INSRMe017-A (STR-I-355-APC)

    France INSERM (INSRM)
    Disease:

    Familial adenomatous polyposis

  155. INSRMe018-A (STR-I-359-APC)

    France INSERM (INSRM)
    Disease:

    Familial adenomatous polyposis

  156. JTUi005-A

    China Sixth People's Hospital, Shanghai Jiao Tong University (JTU)
    Disease:

    Neuronal intranuclear inclusion disease

  157. KAIMRCi003-A (DRVT-iPSC#1)

    Saudi Arabia King Abdullah International Medical Research Center (KAIMRC)
    Disease:

    Dravet syndrome

  158. KAUSTi001-B (KS7-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  159. KAUSTi003-A (KS1-iPSC#D)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  160. KAUSTi004-A (HM-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal

  161. KAUSTi004-B (HM-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal

  162. KAUSTi005-A (HB-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal

  163. KAUSTi005-B (HB-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal

  164. KAUSTi005-C (HB-iPSC#C)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal

  165. KAUSTi006-A (KS6-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  166. KAUSTi006-B (KS6-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  167. KAUSTi007-A (KS2-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  168. KAUSTi007-B (KS2-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  169. KAUSTi008-A (KS4-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  170. KAUSTi008-B (KS4-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  171. KAUSTi008-C (KS4-iPSC#C)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  172. KAUSTi008-D (KS4-iPSC#D)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  173. KAUSTi008-E (KS4-iPSC#E)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  174. KAUSTi008-F (KS4-iPSC#F)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  175. KAUSTi008-G (KS4-iPSC#G)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  176. KAUSTi009-A (KS3-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  177. KAUSTi009-B (KS3-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  178. KAUSTi010-A (KS5-iPSC#A)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  179. KAUSTi010-B (KS5-iPSC#B)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  180. KAUSTi011-A (iPSC-GLP1R-KO-C1)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Developmental and epileptic encephalopathy

  181. KAUSTi011-B (iPSC-GLP1R-KO-H4)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Developmental and epileptic encephalopathy

  182. WAe001-A-I (H1.0-29/H1.1-13)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal

  183. WAe001-A-V (H1.1-39/H1.4-17)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal

  184. KCLi001-A (iOP118)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  185. KCLi002-A (iOP107)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  186. KCLi003-A (iOP101)

    United Kingdom King's College London (KCL)
    Disease:

    Atopic eczema

  187. KEIUi002-A (KOMENT-A)

    Japan Keio University (KEIU)
    Disease:

    Normal

  188. KGUi001-A (AR1023)

    Germany Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital, Goethe University of Frankfurt/Main (KGU)
    Disease:

    Obsolete_bipolar disorder

  189. KGUi002-A (AR1034)

    Germany Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital, Goethe University of Frankfurt/Main (KGU)
    Disease:

    Obsolete_bipolar disorder

  190. KIe001-A-1

    Sweden Karolinska Institutet (KI)
    Disease:

    Normal

  191. KIe053-A (HS983a)

    Sweden Karolinska Institutet (KI)
    Disease:

    Normal

  192. KLRMMEi001-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Retinitis pigmentosa

  193. KLRMMEi003-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Usher syndrome

  194. KRIBBi009-A (KRIBB-BC15)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    Normal

  195. WAe009-A-95 (hTRF1-KO #3)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    Normal

  196. WAe009-A-96 (hTRF1-KO #6)

    South Korea Korea Research Institute of Bioscience and Biotechnology (KRIBB)
    Disease:

    None

  197. KSCBi005-A (CMC-hiPSC-003)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Normal

  198. KSCBi006-A (KNIH-OI001i-A)

    South Korea National Stem Cell Bank (KSCB)
    Disease:

    Osteogenesis imperfecta type 1

  199. BIONi010-C-56 (BIONi010-C-A713T-C25)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  200. BIONi010-C-57 (BIONi010-C-A713T-C42)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  201. BIONi010-C-58 (BIONi010-C-A713T-C1)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  202. BIONi010-C-59 (BIONi010-C-A713T-C33)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  203. BIONi010-C-60 (BIONi010-C-R589C-C7)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  204. BIONi010-C-61 (BIONi010-C-R589C-C16)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  205. BIONi010-C-62 (BIONi010-C-R589C-C5)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  206. BIONi010-C-63 (BIONi010-C-R589C-C9)

    Denmark University of Copenhagen (KU)
    Disease:

    Epilepsy

  207. KUMi001-A (KUMi001-A_CML(Ph+))

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Philadelphia-positive myelogenous leukemia

  208. KUMi002-A (CD34+ CML (Ph-) hiPSCs)

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Chronic myeloid leukemia

  209. KUMi004-A

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Chronic lymphocytic leukemia

  210. KUMi005-A

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Multiple myeloma

  211. KUMi006-A

    South Korea Korea University Medical School Hospital (KUM)
    Disease:

    Multiple myeloma

  212. KUMCi001-A (ALLCD34+)

    South Korea KOREA UNIVERSTY COLLEGE OF MEDICINE (KUMC)
    Disease:

    Acute lymphoblastic leukemia

  213. KUMCi002-A (MM_CD34+iPSCs)

    South Korea KOREA UNIVERSTY COLLEGE OF MEDICINE (KUMC)
    Disease:

    Multiple myeloma

  214. LCPHi001-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Obsolete_parkinson's disease

  215. LCPHi003-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Parkinson's disease

  216. LUMCi029-A (LUMC0072iCTRL01)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal

  217. LUMCi029-B (LUMC0004iCTRL10)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Normal

  218. LUMCi039-A (LQT1-1781G/A hiPSC and LUMC0021iKCNQ-30)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Long qt syndrome 1

  219. MCRIi001-A-1 (PB001-OI26)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Osteogenesis imperfecta

  220. MDCi008-A (8993-B12)

    Germany Max Delbrück Center Berlin Buch (MDC)
    Disease:

    Leigh disease

  221. MDCi009-A (8993-C11)

    Germany Max Delbrück Center Berlin Buch (MDC)
    Disease:

    Leigh disease

  222. MILi001-A (K10 and hFF-iPSCs)

    Germany Miltenyi Biotec B.V. & Co. KG (MIL)
    Disease:

    Normal

  223. MILi001-B (F5)

    Germany Miltenyi Biotec B.V. & Co. KG (MIL)
    Disease:

    Normal

  224. MILi001-C (F10)

    Germany Miltenyi Biotec B.V. & Co. KG (MIL)
    Disease:

    Normal

  225. MMCi001-A (MMC-iPSC-052B-02)

    Taiwan Mackay Medical College (MMC)
    Disease:

    Deafness, autosomal recessive 1a

  226. MPIi002-A (T4 and L1-1Mut)

    Germany Max Planck Institute for Molecular Biomedicine (MPI)
    Disease:

    Obsolete_parkinson's disease

  227. MRIi018-A (HLHS_375)

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Hypoplastic left heart syndrome

  228. MRIi024-A (Shox2.2)

    Germany Klinikum rechts der Isar (MRI)
    Disease:

    Atrial fibrillation

  229. MSKi002-A (C27 and iPS-27)

    United States Memorial Sloan Kettering Cancer Center (MSK)
    Disease:

    Normal

  230. MUi010-A (MYH9)

    Thailand Mahidol University (MU)
    Disease:

    Myh9-related disease

  231. MUi015-A (RB1)

    Thailand Mahidol University (MU)
    Disease:

    Retinoblastoma

  232. MUSIi001-A-2 (HLA-I/II-null SFiPSCs)

    Thailand Faculty of Medicine Siriraj Hospital (MUSI)
    Disease:

    Normal

  233. MUSIi016-A (TyO)

    Thailand Faculty of Medicine Siriraj Hospital (MUSI)
    Disease:

    Normal

  234. NCHi003-A (NCH005)

    United States Nationwide Children's Hospital (NCH)
    Disease:

    Pulmonary valve atresia with intact ventricular septum

  235. NCHi006-A (NCH023)

    United States Nationwide Children's Hospital (NCH)

  236. WAe001-A-65

    China Nanfang Hospital, Southern Medical University (NFYY)
    Disease:

    Epileptic encephalopathy

  237. NIHTVBi028-A

    United States National Institutes of Health-National Heart, Lung, and Blood Institute (NIHTVB)
    Disease:

    Lyn gene mutation

  238. TMOi001-A-5 (DISC1 Ex2 D5)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Normal

  239. NMIi010-A

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Normal

  240. NMIi011-A (B1.4)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  241. NMIi011-B (B1.6)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  242. NMIi011-C (B1.7)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  243. NMIi011-D (B1.10)

    Germany NMI Natural and Medical Sciences Institute at the University of Tübingen (NMI)
    Disease:

    Breast carcinoma

  244. NSi003-A (NSi-DS)

    India Stem Cell and Neurobiology Lab (NS)
    Disease:

    Down syndrome

  245. NSi003-B (NSi-isoEu)

    India Stem Cell and Neurobiology Lab (NS)
    Disease:

    Down syndrome

  246. NTUHi002-A

    Taiwan National Taiwan University Hospital (NTUH)
    Disease:

    Aceruloplasminemia

  247. NUIGi001-A (iPSC ARO1-11)

    Ireland National University of Ireland Galway (NUIG)
    Disease:

    Autosomal recessive osteopetrosis

  248. OTATi001-A (HC4)

    United States Office of Tissues and Advanced Therapies, CBER, FDA (OTAT)
    Disease:

    Normal

  249. PCIi029-A (PC076)

    France PHENOCELL (PCI)
    Disease:

    Waardenburg syndrome type 1

  250. PCIi030-A (PC078)

    France PHENOCELL (PCI)
    Disease:

    Waardenburg syndrome type 1

  251. PCIi031-A (PC079)

    France PHENOCELL (PCI)
    Disease:

    Waardenburg syndrome type 1

  252. PFIZi001-A (EM1-3F)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  253. RCi001-A (Thp3C-6 and RCi88)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  254. RCi001-B (RCi89 and Thp3C-9)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  255. RCi002-A (FP5C-14 and RCi92)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  256. RCi002-B (FP5C-16 and RCi93)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  257. RCi003-A (RCi115 and CIP11A-5)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Pain agnosia

  258. RCi003-B (CIP11A-9 and RCi117)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Pain agnosia

  259. PNUSCRi001-A (GBA PD iPSC7)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Parkinson's disease

  260. PNUSCRi002-A (GBA PD iPSC9)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Parkinson's disease

  261. PNUSCRi003-A (GBA Gaucher iPSC1)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Gaucher disease

  262. PNUSCRi004-A (GBA PD iPSC8)

    South Korea Pusan National University: Convergence Stem Cell Research Center (PNUSCR)
    Disease:

    Parkinson's disease

  263. WAe009-A-47

    China Peking University Third Hospital Department of Cardiology (PUHT)
    Disease:

    Cytochrome-c oxidase deficiency disease

  264. RCi004-A (PDSC-10 and RCi150)

    United Kingdom Roslin Cells (RC)
    Disease:

    Huntington disease

  265. RCe020-A (RC-16 and RC16)

    United Kingdom Roslin Cells (RC)
    Disease:

    Normal

  266. RCMGi001-A (P1L5)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  267. RCMGi002-A (P7L2)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  268. RCMGi004-A (P6L2)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  269. RCMGi004-B (P6L8)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  270. RCMGi005-A (P5L1)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  271. RCMGi005-B (P5L5)

    Russia Research Centre for Medical Genetics (RCMG)
    Disease:

    Cystic fibrosis

  272. RCPCMi003-A (ATXN1KCl2)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Spinocerebellar ataxia type 1

  273. RCPCMi004-A (Park14-4)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Obsolete_parkinson's disease

  274. RCPCMi005-A (IPSP12-1)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Obsolete_parkinson's disease

  275. RCPCMi007-A (IPSFF1S)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Normal

  276. RCPCMi008-A (IPS SCA17 sev cln4)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Spinocerebellar ataxia type 17

  277. RCPCMi009-A (IPSRG4S and UEF-3B)

    Finland Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    Normal

  278. RCPCMi010-A (iPS 67-7)

    Russia Federal State Budgetary Institution Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency (RCPCM)
    Disease:

    X-linked intellectual disability, nascimento type

  279. RCSIi001-A (iPDK)

    Ireland Royal College of Surgeons in Ireland (RCSI)
    Disease:

    Normal

  280. REGUi001-A (IPS4FLV)

    France Institute for Regenerative Medecine & Biotherapy U1183 (REGU)
    Disease:

    Normal

  281. REGUi009-A (myasthenic syndrome due to mutation in ColQ and hiPS 5-9016)

    France Institute for Regenerative Medecine & Biotherapy U1183 (REGU)
    Disease:

    Congenital myasthenic syndrome

  282. RGIe049-A (SI-137)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  283. RGIe050-A (SI-138)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  284. RGIe051-A (SI-139)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  285. RGIe052-A (SI-140)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  286. RGIe053-A (SI-141)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis type 1

  287. RGIe134-A (SI-235)

    United States Reproductive Genetics Institute (RGI)
    Disease:

    Neurofibromatosis

  288. RIi005-A (TYR.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Tyrosinemia type 1

  289. KUIFMSi004-A-1 (hPSC MPP8 Neon Green)

    Russia Pirogov Russian National Research Medical University (RNRMU)
    Disease:

    Normal

  290. RUESe001-A (RUES1)

    United States The Rockefeller University (RUES)
    Disease:

    Normal

  291. RUESe002-A-6 (RUES2-GLR)

    United States The Rockefeller University (RUES)
    Disease:

    Normal

  292. SAPi002-A (ALS I, ALS I–FUS-R514S/wt and FUS-R514S/wt)

    Italy Sapienza University of Rome (SAP)
    Disease:

    Amyotrophic lateral sclerosis

  293. SAPi003-A (ALS II, FUS-R521C/wt and ALS II–FUS-R521C/wt)

    Italy Sapienza University of Rome (SAP)
    Disease:

    Amyotrophic lateral sclerosis

  294. SAPi004-A (ALS III, TDP43-A382T/A382T and ALS III-TDP43-A382T/A382T)

    Italy Sapienza University of Rome (SAP)
    Disease:

    Amyotrophic lateral sclerosis

  295. SBWCHi001-A

    China Shenzhen Baoan Women's and Children's Hospital, Jinan University (SBWCH)
    Disease:

    Ctnnb1 gene mutation

  296. SCAUi001-A

    China South China Agricultural University (SCAU)
    Disease:

    Normal

  297. SCHi001-A-1 (AMN5-Corrected iPSC)

    South Korea Severance Children’s Hospital (SCH)
    Disease:

    Adrenoleukodystrophy

  298. SCVIi073-A (SCVIi574C2)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Dilated cardiomyopathy

  299. SDUe001-A (Odense3)

    Denmark University of Southern Denmark (SDU)

  300. SHEHi002-A (iPS36)

    China Shanghai East Hospital (SHEH)
    Disease:

    Long qt syndrome 8

  301. SMBCi011-A

    China Shandong Medicinal Biotechnology Center (SMBC)
    Disease:

    Prader-willi syndrome

  302. SNUe007-A (SNUhES31)

    South Korea Seoul National University (SNU)
    Disease:

    Normal

  303. UOSe012-A-1

    United Kingdom University of Southampton (SOTON)
    Disease:

    Normal

  304. SPHi001-A (SLEi002HZY)

    China Shenzhen People's Hospital (SPH)
    Disease:

    Systemic lupus erythematosus

  305. WAe009-A-48

    China Shenzhen People's Hospital (SPH)
    Disease:

    Long qt syndrome 3

  306. WAe009-A-74

    China Shenzhen People's Hospital (SPH)
    Disease:

    Long qt syndrome 2

  307. WAe009-A-88

    China Shenzhen People's Hospital (SPH)
    Disease:

    Long qt syndrome 2

  308. SPPHIi003-A

    China Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital (SPPHI)

  309. SUSMi005-A

    United States Stanford University School of Medicine (SUSM)
    Disease:

    Obsolete_parkinson's disease

  310. WAe001-A-81

    China The Seventh Affiliated Hospital (SYSUSH)
    Disease:

    Normal

  311. SZGJMSi001-A (ZLP-2)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Schizophrenia

  312. SZGJMSi002-A (TSQ-1)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Obsessive-compulsive disorder

  313. SZGJMSi003-A (TSH-2)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Normal

  314. SZGJMSi004-A (WJM-1)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Depression

  315. TCIERi001-A (IER-EK1)

    Taiwan Institute of Eye Research, Hualien Tzu Chi Hospital (TCIER)
    Disease:

    Normal

  316. TNRMCi001-A (iTAF32)

    Russia Tomsk National Research Medical Center of the Russian Academy of Sciences (TNRMC)
    Disease:

    Cystic fibrosis

  317. TUSMi001-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Normal

  318. TUSMi002-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Normal

  319. TUSMi003-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Alzheimer's disease

  320. TUSMi004-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsessive-compulsive disorder

  321. TUSMi005-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsolete_bipolar disorder

  322. UCLi005-A (LGMD2D Pt. 4 and LGMD2D #4)

    United Kingdom University College London (UCL)
    Disease:

    Limb-girdle muscular dystrophy

  323. WAe001-A-10 (H1_RB1ex3_G3)

    Germany Universität Duisburg-Essen (UDE)
    Disease:

    Retinoblastoma

  324. UGOTSAi002-B (N1-001iC2)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  325. UGOTSAi003-A (N1-002iC3A)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  326. UGOTSAi003-B (N1-002iC4)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  327. UGOTSAi004-A (N1-003iC3)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  328. UGOTSAi004-B (N1-003iC4)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  329. UGOTSAi005-A (N1-004iC2)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Normal

  330. UGOTSAi005-B (N1-004iC6)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Normal

  331. UGOTSAi006-A (N1-005iC1)

    Sweden The Sahlgrenska Academy at University of Gothenburg (UGOTSA)
    Disease:

    Alzheimer's disease

  332. UIOi001-A (AG27)

    Norway University of Oslo (UIO)
    Disease:

    Normal

  333. UIOi006-A (iPSC APOE4/4: Sporadic AD (Coriell #AG10788, female, Age 87))

    Norway University of Oslo (UIO)

  334. UJSi001-A

    China Jiangsu University (UJS)
    Disease:

    Schizophrenia

  335. UKAi010-A (BM 104-12)

    Germany Universitätsklinikum Aachen (UKA)
    Disease:

    Normal

  336. UKEi001-A (ERC001sv1162)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal

  337. UKEi001-A-1 (CRYABhom)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Desminopathy

  338. UKEi001-B (ERC001sv1352)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal

  339. UKEi001-C (ERC001sv1355)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal

  340. UKEi002-A (ERC017sv2575)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal

  341. UKEi002-C (ERC017sv2596)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal

  342. UKEi003-A (ERC018sv1583)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal

  343. UKEi003-B (ERC018sv1590)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal

  344. UKEi003-C (ERC018sv1634)

    Germany University Medical Center Hamburg-Eppendorf (UKE)
    Disease:

    Normal

  345. HVRDe006-A-1

    United States Universitätsklinikum Erlangen (UKER)
    Disease:

    Coffin-siris syndrome

  346. UKKi035-B (NP0139-B and NP0139-6C)

    Germany Klinikum der Universität zu Köln (UKK)
    Disease:

    Hypertrophic cardiomyopathy

  347. UMILi024-A (CTL04)

    Italy University of Milan (UMIL)
    Disease:

    Normal

  348. WAe009-A-37 (H9-GSX2-tTA:GFP)

    Italy University of Milan (UMIL)
    Disease:

    Normal

  349. UNIPDi004-A

    Italy University of Padova (UNIPD)
    Disease:

    Normal

  350. UNIPDi004-B (HDP04)

    Italy University of Padova (UNIPD)
    Disease:

    Normal

  351. UOSe001-A (MasterShef1, MShef1 and MstrShef1)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  352. UOSe007-A (MstrShef2, MShef2 and MasterShef2)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  353. UOSe008-A (MstrShef3, MShef3 and MasterShef3)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  354. UOSe009-A (MstrShef4, MShef4 and MasterShef4)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  355. UOSe010-A (MstrShef5, MShef5 and MasterShef5)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  356. UOSe011-A (MstrShef6, MShef6 and MasterShef6)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  357. UOSe012-A (MstrShef7, MShef7 and MasterShef7)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  358. UOSe013-A (MstrShef8, MasterShef8 and MShef8)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  359. UOSe014-A (MasterShef10, MShef10 and MstrShef10)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  360. UOSe015-A (MasterShef11, MstrShef11 and MShef11)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  361. UOSe016-A (MasterShef12, MShef12 and MstrShef12)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  362. UOSe017-A (MasterShef13, MstrShef13 and MShef13)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  363. UOSe018-A (MasterShef14, MShef14 and MstrShef14)

    United Kingdom University of Sheffield (UOS)
    Disease:

    Normal

  364. VIACe001-A-1 (BG01V/hOG)

    United States Novocell, Inc. (VIAC)

  365. WAe001-A (WA01 and H1)

    United States WiCell Research Institute (WA)
    Disease:

    Normal

  366. WAe007-A (H7 and WA07)

    United States WiCell Research Institute (WA)
    Disease:

    Normal

  367. WAe009-A (WA09 and H9)

    United States WiCell Research Institute (WA)
    Disease:

    Normal

  368. WAe013-A (WA13 and H13)

    United States WiCell Research Institute (WA)

  369. WAe014-A (WA14 and H14)

    United States WiCell Research Institute (WA)

  370. WIBRe001-A-2 (WIBR3 Oct4-2A-GFP)

    United States Whitehead Institute for Biomedical Research (WIBR)
    Disease:

    Normal

  371. WIBRe004-A (WIN1 and Whitehead Institute Naive Human 1)

    United States Whitehead Institute for Biomedical Research (WIBR)
    Disease:

    Normal

  372. WTSIi001-A (HPSI1213i-pahc_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  373. WTSIi037-A (HPSI0114i-zoxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  374. WTSIi038-A (HPSI1113i-ieki_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  375. WTSIi046-B (HPSI0214i-wibj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  376. WTSIi047-B (HPSI0814i-bokz_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  377. WTSIi049-A (HPSI0514i-wiii_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  378. WTSIi049-B (HPSI0514i-wiii_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  379. WTSIi052-A (HPSI1114i-ziyn_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  380. WTSIi053-A (HPSI0413i-corn_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  381. WTSIi054-B (HPSI0413i-nudd_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  382. WTSIi056-A (HPSI0513i-dipe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  383. WTSIi057-B (HPSI0513i-giuf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  384. WTSIi059-A (HPSI0513i-uilw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  385. WTSIi063-A (HPSI0613i-aevs_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  386. WTSIi068-B (HPSI0613i-giuo_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  387. WTSIi069-A (HPSI0613i-hegp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  388. WTSIi073-A (HPSI0314i-sojd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  389. WTSIi082-A (HPSI1013i-cups_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  390. WTSIi083-A (HPSI1213i-xuja_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  391. WTSIi085-A (HPSI1113i-eofe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  392. WTSIi086-A (HPSI0913i-coyi_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  393. WTSIi098-A (HPSI1213i-nekd_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  394. WTSIi102-A (HPSI0413i-iakz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  395. WTSIi102-B (HPSI0413i-iakz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  396. WTSIi103-A (HPSI1213i-nusw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  397. WTSIi104-A (HPSI0513i-coio_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  398. WTSIi104-B (HPSI0513i-coio_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  399. WTSIi105-A (HPSI0313i-airc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  400. WTSIi105-B (HPSI0313i-airc_66)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  401. WTSIi106-B (HPSI0613i-hikj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  402. WTSIi109-A (HPSI0413i-coxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  403. WTSIi109-B (HPSI0413i-coxy_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  404. WTSIi110-A (HPSI0713i-darw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  405. WTSIi111-A (HPSI0513i-euir_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  406. WTSIi112-A (HPSI0613i-funp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  407. WTSIi114-A (HPSI0513i-golb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  408. WTSIi115-A (HPSI0513i-iasn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  409. WTSIi116-A (HPSI0813i-iicq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  410. WTSIi117-A (HPSI0613i-liun_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  411. WTSIi118-A (HPSI0813i-meqo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  412. WTSIi119-A (HPSI0613i-oefg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  413. WTSIi120-A (HPSI0513i-oeoo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  414. WTSIi121-A (HPSI0413i-ougl_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  415. WTSIi121-B (HPSI0413i-ougl_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  416. WTSIi122-A (HPSI0413i-peop_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  417. WTSIi123-A (HPSI0713i-qimz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  418. WTSIi124-A (HPSI0713i-ruyv_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  419. WTSIi124-B (HPSI0713i-ruyv_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  420. WTSIi125-A (HPSI0413i-uahf_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  421. WTSIi126-A (HPSI0913i-vopm_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  422. WTSIi127-A (HPSI0413i-xekf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  423. WTSIi128-A (HPSI0413i-yuze_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  424. WTSIi129-A (HPSI0613i-zisa_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  425. WTSIi130-A (HPSI0713i-aehn_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  426. WTSIi131-A (HPSI0513i-aipt_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  427. WTSIi133-A (HPSI0713i-dard_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  428. WTSIi133-B (HPSI0713i-dard_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  429. WTSIi134-B (HPSI0513i-dulv_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  430. WTSIi137-A (HPSI0613i-lizq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  431. WTSIi137-B (HPSI0613i-lizq_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  432. WTSIi138-A (HPSI0414i-mita_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  433. WTSIi139-A (HPSI1113i-oaaz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  434. WTSIi140-A (HPSI0613i-oomz_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  435. WTSIi141-A (HPSI0613i-qanu_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  436. WTSIi142-A (HPSI0613i-qony_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  437. WTSIi144-A (HPSI0114i-wegi_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  438. WTSIi145-A (HPSI0813i-wots_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  439. WTSIi146-A (HPSI0613i-xosg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  440. WTSIi168-A (HPSI0214i-poih_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  441. WTSIi168-B (HPSI0214i-poih_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  442. WTSIi169-A (HPSI0614i-miaj_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  443. WTSIi170-A (HPSI1213i-tolg_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  444. WTSIi170-B (HPSI1213i-tolg_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  445. WTSIi171-A (HPSI0914i-zerv_7)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  446. WTSIi171-B (HPSI0914i-zerv_8)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  447. WTSIi172-A (HPSI0914i-laey_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  448. WTSIi172-B (HPSI0914i-laey_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  449. WTSIi173-A (HPSI0414i-naju_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  450. WTSIi174-A (HPSI0614i-paab_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  451. WTSIi175-A (HPSI1014i-tixi_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  452. WTSIi176-B (HPSI0714i-iudw_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  453. WTSIi177-A (HPSI0414i-xojn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  454. WTSIi178-B (HPSI0215i-fawm_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  455. WTSIi179-A (HPSI0314i-wigw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  456. WTSIi180-A (HPSI0514i-puie_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  457. WTSIi180-B (HPSI0514i-puie_5)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  458. WTSIi181-A (HPSI0514i-rutc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  459. WTSIi182-A (HPSI0614i-kegd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  460. WTSIi183-A (HPSI0414i-oaqd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  461. WTSIi183-B (HPSI0414i-oaqd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  462. WTSIi184-A (HPSI1014i-qayj_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  463. WTSIi184-B (HPSI1014i-qayj_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  464. WTSIi186-A (HPSI1014i-babz_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  465. WTSIi187-A (HPSI1013i-sita_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  466. WTSIi188-A (HPSI1014i-kefb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  467. WTSIi189-A (HPSI1014i-quls_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  468. WTSIi190-A (HPSI0914i-kajh_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  469. WTSIi191-A (HPSI0215i-oilg_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  470. XACHi004-A

    China Xi'an children's hospital (XACH)
    Disease:

    Atrial fibrillation

  471. YBLi004-A (YBL/SH/2018/0062)

    India Yashraj Biotechnology ltd Navi Mumbai India (YBL)

  472. YBLi005-A (YBL/OS/2021/00196)

    India Yashraj Biotechnology ltd Navi Mumbai India (YBL)

  473. YBLi006-A (YBL/PH/2022/0025)

    India Yashraj Biotechnology ltd Navi Mumbai India (YBL)

  474. ZJSHi001-A (ZJSHi-KCNB1)

    China Department of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine (ZJSH)
    Disease:

    Developmental and epileptic encephalopathy, 26

  475. WAe009-A-B

    China Zhengzhou Central Hospital Affiliated (ZZCH)
    Disease:

    Heart failure

  476. ZZUNEUi010-A (CMF001-A)

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Juvenile amyotrophic lateral sclerosis

  477. ZZUNEUi026-A

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Hypertrophic cardiomyopathy

  478. WAe009-A-C

    China The Second Affiliated Hospital (ZZUSA)
    Disease:

    Heart failure